121 related articles for article (PubMed ID: 26074402)
1. Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.
Vrachimis A; Wenning C; Gerß J; Dralle H; Vaez Tabassi M; Schober O; Riemann B;
J Surg Oncol; 2015 Jul; 112(1):9-14. PubMed ID: 26074402
[TBL] [Abstract][Full Text] [Related]
2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
3. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
[TBL] [Abstract][Full Text] [Related]
4. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
5. Selective lateral compartment neck dissection for thyroid cancer.
Welch K; McHenry CR
J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
[TBL] [Abstract][Full Text] [Related]
6. Recurrence and mortality in patients with differentiated thyroid carcinoma.
Noguchi M; Yagi H; Earashi M; Kinoshita K; Miyazaki I; Mizukami Y
Int Surg; 1995; 80(2):162-6. PubMed ID: 8530235
[TBL] [Abstract][Full Text] [Related]
7. Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.
Schvartz C; Bonnetain F; Dabakuyo S; Gauthier M; Cueff A; Fieffé S; Pochart JM; Cochet I; Crevisy E; Dalac A; Papathanassiou D; Toubeau M
J Clin Endocrinol Metab; 2012 May; 97(5):1526-35. PubMed ID: 22344193
[TBL] [Abstract][Full Text] [Related]
8. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
9. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
10. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
11. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
12. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment of differentiated thyroid carcinoma and analysis of recurrence-related factors].
Chen FJ; Li QL; Zeng ZY; Song M; Yang AK; Zhang Q
Ai Zheng; 2004 Nov; 23(11):1311-6. PubMed ID: 15522180
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
Kim M; Jeon MJ; Oh HS; Park S; Song DE; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
Thyroid; 2018 Apr; 28(4):496-503. PubMed ID: 29620964
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
Fritze D; Doherty GM
Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
[TBL] [Abstract][Full Text] [Related]
16. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
18. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
19. [Should cervical lymph nodes be electively removed in differentiated thyroid carcinoma?].
Herman K; Wysocki W; Fortuna J
Wiad Lek; 2001; 54 Suppl 1():205-9. PubMed ID: 12182026
[TBL] [Abstract][Full Text] [Related]
20. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
